Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-27T12:36:29.454Z Has data issue: false hasContentIssue false

Chapter 42 - Pituitary and Adrenal Disease in Pregnancy (Content last reviewed: 14th December 2020)

from Section 5 - Late Pregnancy – Maternal Problems

Published online by Cambridge University Press:  15 November 2017

By
Heather A. Frey  and
Mark B. Landon
Edited by
David James ,
Philip Steer ,
Carl Weiner ,
Bernard Gonik  and
Stephen Robson
David James
Affiliation:
University of Nottingham
Philip Steer
Affiliation:
Imperial College London
Carl Weiner
Affiliation:
University of Kansas
Bernard Gonik
Affiliation:
Wayne State University, Detroit
Stephen Robson
Affiliation:
University of Newcastle
Get access

Summary

The anterior lobe of the pituitary gland may enlarge significantly during pregnancy as a result of lactotroph proliferation. Magnetic resonance imaging (MRI) scans confirm that the gland more than doubles in size by the end of gestation.

Type
Chapter
Information
High-Risk Pregnancy
Management Options
 , pp. 1217 - 1234
Publisher: Cambridge University Press
First published in: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gonzalez, JG, Elizondo, G, Saldivar, D, et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988; 85: 217–20.Google Scholar
Tyson, JE, Hwang, P, Guyda, H, Friesen, HG. Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 1972; 113: 14–20.Google Scholar
Karaca, Z, Tanriverdi, F, Unluhizarci, K, Kelestimur, F. Pregnancy and pituitary disorders. Eur J Endocrinol 2010; 162: 453–75.Google Scholar
Eriksson, L, Frankenne, F, Eden, S, Hennen, G, Von Schoultz, B. Growth hormone 24-h serum profiles during pregnancy: lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 1989; 96: 949–53.Google Scholar
Samaan, NA, Goplerud, CP, Bradbury, JT. Effect of arginine infusion on plasma levels of growth hormone, insulin, and glucose during pregnancy and the puerperium. Am J Obstet Gynecol 1970; 107: 1002–7.Google Scholar
Carr, BR, Parker, CR Jr., Madden, JD, MacDonald, PC, Porter, JC. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol 1981; 139: 416–22.Google Scholar
Davison, JM, Sheills, EA, Barron, WM, Robinson, AG, Lindheimer, MD. Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy. J Clin Invest 1989; 83: 1313–18.Google Scholar
Gemzell, C, Wang, CF. Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979; 31: 363–72.Google Scholar
Huang, W, Molitch, ME. Pituitary tumors in pregnancy. Endocrinol Metab Clin N Am 2019; 48: 569–81.Google Scholar
Magyar, DM, Marshall, JR. Pituitary tumors and pregnancy. Am J Obstet Gynecol 1978; 132: 739–51.Google Scholar
Melmed, S, Casanueva, FF, Hoffman, AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273–88.Google Scholar
Wang, AT, Mullan, RJ, Lane, MA, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev 2012; 1: 33.Google Scholar
Molitch, ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab 2011; 25: 885–96.Google Scholar
Divers, WA, Yen, SS. Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 1983; 62: 425–9.Google Scholar
van Roon, E, van der Vijver, JC, Gerretsen, G, Hekster, RE, Wattendorff, RA. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy. Fertil Steril 1981; 36: 173–7.Google Scholar
Tan, SL, Jacobs, HS. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy. Int J Gynaecol Obstet 1986; 24: 209–15.Google Scholar
Auriemma, RS, Perone, Y, Di Sarno, A, Grasso, LF, Guerra, E, Gasperi, M, et al. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab 2013; 98: 372–9.Google Scholar
Domingue, ME, Devuyst, F, Alexopoulou, O, Corvilain, B, Maiter, D. Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. Clin Endocrinol 2014; 80: 642–8.Google Scholar
Katznelson, L, Laws, ER, Melmed, S, et al. Acromegaly: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 3933–51.Google Scholar
Caron, P, Broussaud, S, Bertherat, J, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 2010; 95: 4680–7.Google Scholar
Kasuki, L, Neto, LV, Takiya, CM, Gadelha, MR. Growth of an aggressive tumor during pregnancy in an acromegalic patient. Endocr J 2012; 59: 313–19.Google Scholar
Cozzi, R, Attanasio, R, Barausse, M. Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 2006; 155: 279–84.Google Scholar
Abucham, J, Bronstein, MD, Dias, ML. Management of endocrine disease. Acromegaly and pregnancy: a contemporary review. Eur J Endocrinol 2017; 177(1): R1–12. doi: 10.1530/EJE-16-1059.Google Scholar
Caufriez, A, Frankenne, F, Hennen, G, Copinschi, G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 1993; 265: E572–7.Google Scholar
Fassnacht, M, Capeller, B, Arlt, W, Steck, T, Allolio, B. Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol 2001; 55: 411–15.Google Scholar
Cheng, S, Grasso, L, Martinez-Orozco, JA, et al. Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol 2012; 76: 264–71.Google Scholar
Vialon, M, Grunenwald, S, Mouly, C, et al. First-generation somatostatin receptor ligands and pregnancy: lesson from women with acromegaly. Endocrine 2020; 70: 396–403. https://doi.org/10.1007/s12020-020-02430-1.Google Scholar
Brian, SR, Bidlingmaier, M, Wajnrajch, MP, Weinzimer, SA, Inzucchi, SE. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 2007; 92: 3374–7.Google Scholar
Iwasaki, Y, Oiso, Y, Kondo, K, et al. Aggravation of subclinical diabetes insipidus during pregnancy. N Eng J Med 1991; 324: 522–6.Google Scholar
Jin-no, Y, Kamiya, Y, Okada, M, et al. Pregnant woman with transient diabetes insipidus resistant to 1-desamino-8-D-arginine vasopressin. Endocr J 1998; 45: 693–6.Google Scholar
Hime, MC, Richardson, JA. Diabetes insipidus and pregnancy. Case report, incidence and review of literature. Obstet Gynecol Surv 1978; 33: 375–9.Google Scholar
Durr, JA, Hoggard, JG, Hunt, JM, Schrier, RW. Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity. N Eng J Med 1987; 316: 1070–4.Google Scholar
Kalelioglu, I, Kubat, Uzum A, Yildirim, A, et al. Transient gestational diabetes insipidus diagnosed in successive pregnancies: review of pathophysiology, diagnosis, treatment, and management of delivery. Pituitary 2007; 10: 87–93.Google Scholar
Cammu, H, Velkeniers, B, Charels, K, Vincken, W, Amy, JJ. Idiopathic acute fatty liver of pregnancy associated with transient diabetes insipidus. Case report. Br J Obstet Gynaecol 1987; 94: 173–8.Google Scholar
Kennedy, S, Hall, PM, Seymour, AE, Hague, WM. Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol 1994; 101: 387–91.Google Scholar
Brewster, UC, Hayslett, JP. Diabetes insipidus in the third trimester of pregnancy. Obstet Gynecol 2005; 105: 1173–6.CrossRefGoogle ScholarPubMed
Ananthakrishnan, S. Gestational diabetes insipidus: diagnosis and management. Best Pract Res Clin Endocrinol Metab 2020; 34(5): 101384. https://doi.org/10.1016/j.beem.2020.101384.Google Scholar
Garofeanu, CG, Weir, M, Rosas-Arellano, MP, et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 2005; 45: 626–37.Google Scholar
Burrow, GN, Wassenaar, W, Robertson, GL, Sehl, H. DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period. Acta Endocrinol 1981; 97: 23–5.Google Scholar
Shangold, MM, Freeman, R, Kumaresan, P, Feder, AS, Vasicka, A. Plasma oxytocin concentrations in a pregnant woman with total vasopressin deficiency. Obstet Gynecol 1983; 61: 662–7.Google Scholar
Sheehan, HL. Postpartum necrosis of the anterior pituitary. J Pathol Bacteriol 1937; 45: 189–214.Google Scholar
Kelestimur, F. Sheehan’s syndrome. Pituitary. 2003; 6(4):181–8.Google Scholar
Sert, M, Tetiker, T, Kirim, S, Kocak, M. Clinical report of 28 patients with Sheehan’s syndrome. Endocr J 2003; 50: 297–301.Google Scholar
Grimes, HG, Brooks, MH. Pregnancy in Sheehan’s syndrome: report of a case and review. Obstet Gynecol Surv 1980; 35: 481–8.CrossRefGoogle ScholarPubMed
Caturegli, P, Newschaffer, C, Olivi, A, et al. Autoimmune hypophysitis. Endocr Rev 2005; 26: 599–614.Google Scholar
Khare, S, Jagtap, VS, Budyal, SR, et al. Primary (autoimmune) hypophysitis: a single center experience. Pituitary 2015; 18: 16–22. doi: 10.1007/s11102-013-0550-9.Google Scholar
Chiloiro, S, Tartaglione, T, Angelini, F, et al. An overview of diagnosis of primary autoimmune hypophysitis in a prospective single-center experience. Neuroendocrinology 2017; 104: 280–90. doi: 10.1159/000446544.Google Scholar
Portocarrero, CJ, Robinson, AG, Taylor, AL, Klein, I. Lymphoid hypophysitis. An unusual cause of hyperprolactinemia and enlarged sella turcica. JAMA 1981; 246: 1811–12.CrossRefGoogle ScholarPubMed
Dorfman, SG, Dillaplain, RP, Gambrell, RD. Antepartum pituitary infarction. Obstet Gynecol 1979; 53: 21S–24S.Google Scholar
Piantanida, E, Gallo, D, Lombardi, V, et al. Pituitary apoplexy during pregnancy: a rare, but dangerous headache. J Endocrinol Invest 2014; 37: 789–97.Google Scholar
Motivala, S, Gologorsky, Y, Kostandinov, J, Post, KD. Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 2011; 40: 827–36.Google Scholar
Fleseriu, M, Hashim, IA, Karavitaki, N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 3888–921. doi: 10.1210/jc.2016-2118.Google Scholar
Vila, G, Akerblad, A, Mattsson, A, et al. Pregnancy outcomes in women with growth hormone deficiency. Fertil Steril 2015; 104: 1210–17.e1. doi: 10.1016/j.fertnstert.2015.07.1132.Google Scholar
Grossman, R, Mukherjee, D, Chaichana, KL, et al. Complications and death among elderly patients undergoing pituitary tumour surgery. Clin Endocrinol 2010; 73: 361–8.Google Scholar
Jung, C, Ho, JT, Torpy, DJ, Rogers, A, Doogue, M, Lewis, JG, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 2011; 96: 1533–40.Google Scholar
Robinson, BG, Emanuel, RL, Frim, DM, Majzoub, JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A 1988; 85: 5244–8.Google Scholar
Dorr, HG, Heller, A, Versmold, HT, et al. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 1989; 68: 863–8.Google Scholar
Lindsay, JR, Nieman, LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005; 26: 775–99.Google Scholar
Aron, DC, Schnall, AM, Sheeler, LR. Cushing’s syndrome and pregnancy. Am J Obstet Gynecol 1990; 162: 244–52.Google Scholar
Buescher, MA, McClamrock, HD, Adashi, EY. Cushing syndrome in pregnancy. Obstet Gynecol 1992; 79: 130–7.Google Scholar
Achong, N, D’Emden, M, Fagermo, N, Mortimer, R. Pregnancy-induced Cushing’s syndrome in recurrent pregnancies: case report and literature review. Aust N Z J Obstet Gynaecol 2012; 52: 96–100.Google Scholar
Hana, V, Dokoupilova, M, Marek, J, Plavka, R. Recurrent ACTH-independent Cushing’s syndrome in multiple pregnancies and its treatment with metyrapone. Clin Endocrinol 2001; 54: 277–81.Google Scholar
Xu, JJ, Wang, YJ, Shan, LZ, Gu, W, Zeng, WH. Recurrent ACTH-independent Cushing’s syndrome in multiple pregnancies. Gynecol Endocrinol 2013; 29: 309–10.CrossRefGoogle ScholarPubMed
Lindsay, JR, Jonklaas, J, Oldfield, EH, Nieman, LK. Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 2005; 90: 3077–83.Google Scholar
Koerten, JM, Morales, WJ, Washington, SR, Castaldo, TW. Cushing’s syndrome in pregnancy: a case report and literature review. Am J Obstet Gynecol 1986; 154: 626–8.Google Scholar
Nieman, LK, Biller, BM, Findling, JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 1526–40.Google Scholar
Manetti, L, Rossi, G, Grasso, L, et al. Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol. Eur J Endocrinol 2013; 168: 315–21.Google Scholar
Lopes, LM, Francisco, RP, Galletta, MA, Bronstein, MD. Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing–s disease. Pituitary 2016; 19: 30–8. doi: 10.1007/s11102-015-0680-3.Google Scholar
Odagiri, E, Demura, R, Demura, H, et al. The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing’s disease. Endocrinol Jpn 1988; 35: 795–802.Google Scholar
Terhune, KP, Jagasia, S, Blevins, LS, Phay, JE. Diagnostic and therapeutic dilemmas of hypercortisolemia during pregnancy: a case report. Am Surg 2009; 75: 232–4.Google Scholar
Lim, WH, Torpy, DJ, Jeffries, WS. The medical management of Cushing’s syndrome during pregnancy. Eur J Obstet Gynecol Reprod Biol 2013; 168: 1–6.Google Scholar
Riester, A, Reincke, M. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol 2015; 172: R23–30.CrossRefGoogle ScholarPubMed
Wyckoff, JA, Seely, EW, Hurwitz, S, et al. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 2000; 35: 668–72.Google Scholar
Ronconi, V, Turchi, F, Zennaro, MC, Boscaro, M, Giacchetti, G. Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism. Clin Endocrinol 2011; 74: 278–9.Google Scholar
Funder, JW, Carey, RM, Fardella, C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266–81.Google Scholar
Lu, W, Zheng, F, Li, H, Ruan, L. Primary aldosteronism and pregnancy: a case report. Aust N Z J Obstet Gynaecol 2009; 49: 558.Google Scholar
Okawa, T, Asano, K, Hashimoto, T, et al. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol 2002; 19: 31–6.Google Scholar
Kamoun, M, Mnif, MF, Charfi, N, et al. Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies. Am J Med Sci 2014; 347: 64–73.Google Scholar
Lotgering, FK, Derkx, FM, Wallenburg, HC. Primary hyperaldosteronism in pregnancy. Am J Obstet Gynecol 1986; 155: 986–8.Google Scholar
Bothou, C, Anand, G, Li, D, et al. Current management and outcome of pregnancies in women with adrenal insuffiency: experience from a multicenter survey. J Clin Endorinol Metab 2020; 105: e2853–63. https://doi.org/10.1210/clinem/dgaa266.Google Scholar
Cabassi, A, Rocco, R, Berretta, R, Regolisti, G, Bacchi-Modena, A. Eplerenone use in primary aldosteronism during pregnancy. Hypertension 2012; 59: e18–19.Google Scholar
Björnsdottir, S, Cnattingius, S, Brandt, L, et al. Addison’s disease in women is a risk factor for an adverse pregnancy outcome. J Clin Endocrinol Metab 2010; 95: 5249–57. https://doi.org/10.1210/jc.2010-0108.Google Scholar
Schneiderman, M, Czuzoj-Shulman, N, Spence, AR, Abenhaim HA. Maternal and neonatal outcomes of pregnancies in women with Addison’s disease: a population-based cohort study on 7.7 million births. BJOG 2017; 124: 1772–9. https://doi.org/10.1111/1471-0528.14448.Google Scholar
McKenna, DS, Wittber, GM, Nagaraja, HN, Samuels, P. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function. Am J Obstet Gynecol 2000; 183: 669–73.Google Scholar
Yuen, KC, Chong, LE, Koch, CA. Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management. Endocrine 2013; 44: 283–92.Google Scholar
Lebbe, M, Arlt, W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol 2013; 78: 497–502. doi: 10.1111/cen.12097.Google Scholar
Bornstein, SR, Allolio, B, Arlt, W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 364–89. doi: 10.1210/jc.2015-1710.Google Scholar
Bancos, I, Hahner, S, Tomlinson, J, Arlt, W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015; 3: 216–26. doi: 10.1016/S2213-8587(14)70142-1.Google Scholar
Bornstein, SR, Allolio, B, Arlt, W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 264–89. doi: 10.1210/jc.2015-1710.Google Scholar
Lenders, JW. Pheochromocytoma and pregnancy: a deceptive connection. Eur J Endocrinol 2012; 166: 143–50.Google Scholar
Biggar, MA, Lennard, TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg 2013; 100: 182–90.Google Scholar
Lenders, JW, Duh, QY, Eisenhofer, G, et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 1915–42.Google Scholar
Lenders, JWM, Langton, K, Langenhuijsen, JF, Eisenhofer, G. Pheochromocytoma and pregnancy. Endocrinol Metab Clin North Am 2019; 48: 605–17. https://doi.org/10.1016/j.ecl.2019.05.006.Google Scholar
Schenker, JG, Chowers, I. Pheochromocytoma and pregnancy: review of 89 cases. Obstet Gynecol Surv 1971; 26: 739–47.Google Scholar
Finkenstedt, G, Gasser, RW, Hofle, G, et al. Pheochromocytoma and sub-clinical Cushing’s syndrome during pregnancy: diagnosis, medical pre-treatment and cure by laparoscopic unilateral adrenalectomy. J Endocrinol Invest 1999; 22: 551–7.Google Scholar
Song, Y, Liu, J, Li, H, et al. Outcomes of concurrent Caesarean delivery and pheochromocytoma resection in late pregnancy. Intern Med J 2013; 43: 588–91.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×